ALKERMES PLC (ALKS) Stock Fundamental Analysis

NASDAQ:ALKS • IE00B56GVS15

30.73 USD
-0.31 (-1%)
At close: Feb 26, 2026
30.73 USD
0 (0%)
After Hours: 2/26/2026, 4:30:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALKS. ALKS was compared to 521 industry peers in the Biotechnology industry. ALKS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALKS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ALKS had positive earnings in the past year.
  • ALKS had a positive operating cash flow in the past year.
  • In multiple years ALKS reported negative net income over the last 5 years.
  • ALKS had a positive operating cash flow in 4 of the past 5 years.
ALKS Yearly Net Income VS EBIT VS OCF VS FCFALKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • ALKS has a Return On Assets of 14.57%. This is amongst the best in the industry. ALKS outperforms 95.39% of its industry peers.
  • The Return On Equity of ALKS (19.58%) is better than 95.59% of its industry peers.
  • ALKS has a Return On Invested Capital of 16.22%. This is amongst the best in the industry. ALKS outperforms 96.35% of its industry peers.
Industry RankSector Rank
ROA 14.57%
ROE 19.58%
ROIC 16.22%
ROA(3y)8.82%
ROA(5y)3.68%
ROE(3y)13.16%
ROE(5y)4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ALKS Yearly ROA, ROE, ROICALKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • ALKS has a Profit Margin of 22.30%. This is amongst the best in the industry. ALKS outperforms 94.24% of its industry peers.
  • With an excellent Operating Margin value of 23.59%, ALKS belongs to the best of the industry, outperforming 95.39% of the companies in the same industry.
  • With an excellent Gross Margin value of 86.04%, ALKS belongs to the best of the industry, outperforming 88.68% of the companies in the same industry.
  • ALKS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.59%
PM (TTM) 22.3%
GM 86.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.43%
GM growth 5Y-0.08%
ALKS Yearly Profit, Operating, Gross MarginsALKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • ALKS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for ALKS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALKS Yearly Shares OutstandingALKS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ALKS Yearly Total Debt VS Total AssetsALKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • ALKS has an Altman-Z score of 6.50. This indicates that ALKS is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ALKS (6.50) is better than 74.47% of its industry peers.
  • There is no outstanding debt for ALKS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.5
ROIC/WACC2.06
WACC7.86%
ALKS Yearly LT Debt VS Equity VS FCFALKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 3.67 indicates that ALKS has no problem at all paying its short term obligations.
  • ALKS has a Current ratio (3.67) which is in line with its industry peers.
  • ALKS has a Quick Ratio of 3.27. This indicates that ALKS is financially healthy and has no problem in meeting its short term obligations.
  • ALKS's Quick ratio of 3.27 is in line compared to the rest of the industry. ALKS outperforms 41.07% of its industry peers.
Industry RankSector Rank
Current Ratio 3.67
Quick Ratio 3.27
ALKS Yearly Current Assets VS Current LiabilitesALKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • ALKS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.90%.
  • ALKS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.43% yearly.
EPS 1Y (TTM)-34.9%
EPS 3Y77.08%
EPS 5Y34.43%
EPS Q2Q%-56.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.57%

3.2 Future

  • Based on estimates for the next years, ALKS will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.40% on average per year.
  • ALKS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.44% yearly.
EPS Next Y-20.69%
EPS Next 2Y-9.41%
EPS Next 3Y3.97%
EPS Next 5Y8.4%
Revenue Next Year23.02%
Revenue Next 2Y12.82%
Revenue Next 3Y10.55%
Revenue Next 5Y10.44%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
ALKS Yearly Revenue VS EstimatesALKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B
ALKS Yearly EPS VS EstimatesALKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.26 indicates a correct valuation of ALKS.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALKS indicates a rather cheap valuation: ALKS is cheaper than 95.59% of the companies listed in the same industry.
  • ALKS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.05.
  • A Price/Forward Earnings ratio of 20.52 indicates a rather expensive valuation of ALKS.
  • ALKS's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALKS is cheaper than 92.90% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ALKS to the average of the S&P500 Index (28.03), we can say ALKS is valued slightly cheaper.
Industry RankSector Rank
PE 16.26
Fwd PE 20.52
ALKS Price Earnings VS Forward Price EarningsALKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALKS is valued cheaper than 97.70% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALKS indicates a rather cheap valuation: ALKS is cheaper than 98.08% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.33
EV/EBITDA 9.04
ALKS Per share dataALKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The decent profitability rating of ALKS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.47
EPS Next 2Y-9.41%
EPS Next 3Y3.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALKS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALKERMES PLC

NASDAQ:ALKS (2/26/2026, 4:30:00 PM)

After market: 30.73 0 (0%)

30.73

-0.31 (-1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)04-29
Inst Owners105.82%
Inst Owner Change1.64%
Ins Owners1.48%
Ins Owner Change5.39%
Market Cap5.07B
Revenue(TTM)N/A
Net Income(TTM)339.32M
Analysts80.87
Price Target44.69 (45.43%)
Short Float %11.74%
Short Ratio10.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)66.1%
Min EPS beat(2)59.84%
Max EPS beat(2)72.36%
EPS beat(4)4
Avg EPS beat(4)43.68%
Min EPS beat(4)12.02%
Max EPS beat(4)72.36%
EPS beat(8)4
Avg EPS beat(8)10.27%
EPS beat(12)8
Avg EPS beat(12)42.89%
EPS beat(16)11
Avg EPS beat(16)151.46%
Revenue beat(2)2
Avg Revenue beat(2)10.32%
Min Revenue beat(2)8.51%
Max Revenue beat(2)12.13%
Revenue beat(4)3
Avg Revenue beat(4)7.62%
Min Revenue beat(4)-1.19%
Max Revenue beat(4)12.13%
Revenue beat(8)4
Avg Revenue beat(8)3.11%
Revenue beat(12)7
Avg Revenue beat(12)3.8%
Revenue beat(16)10
Avg Revenue beat(16)3.09%
PT rev (1m)0.29%
PT rev (3m)0.57%
EPS NQ rev (1m)-1.13%
EPS NQ rev (3m)-3.14%
EPS NY rev (1m)-0.46%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 16.26
Fwd PE 20.52
P/S 3.34
P/FCF 10.33
P/OCF 9.38
P/B 2.93
P/tB 3.08
EV/EBITDA 9.04
EPS(TTM)1.89
EY6.15%
EPS(NY)1.5
Fwd EY4.87%
FCF(TTM)2.98
FCFY9.68%
OCF(TTM)3.27
OCFY10.66%
SpS9.21
BVpS10.5
TBVpS9.99
PEG (NY)N/A
PEG (5Y)0.47
Graham Number21.13
Profitability
Industry RankSector Rank
ROA 14.57%
ROE 19.58%
ROCE 19.34%
ROIC 16.22%
ROICexc 40.45%
ROICexgc 45.58%
OM 23.59%
PM (TTM) 22.3%
GM 86.04%
FCFM 32.29%
ROA(3y)8.82%
ROA(5y)3.68%
ROE(3y)13.16%
ROE(5y)4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.43%
GM growth 5Y-0.08%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 163.07%
Cap/Sales 3.25%
Interest Coverage 250
Cash Conversion 138.93%
Profit Quality 144.77%
Current Ratio 3.67
Quick Ratio 3.27
Altman-Z 6.5
F-Score6
WACC7.86%
ROIC/WACC2.06
Cap/Depr(3y)76.88%
Cap/Depr(5y)63.55%
Cap/Sales(3y)2.83%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.9%
EPS 3Y77.08%
EPS 5Y34.43%
EPS Q2Q%-56.19%
EPS Next Y-20.69%
EPS Next 2Y-9.41%
EPS Next 3Y3.97%
EPS Next 5Y8.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.57%
Revenue Next Year23.02%
Revenue Next 2Y12.82%
Revenue Next 3Y10.55%
Revenue Next 5Y10.44%
EBIT growth 1Y-17.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.47%
EBIT Next 3Y8.62%
EBIT Next 5Y12.64%
FCF growth 1Y93.4%
FCF growth 3Y76.56%
FCF growth 5YN/A
OCF growth 1Y83.22%
OCF growth 3Y62.84%
OCF growth 5Y43.53%

ALKERMES PLC / ALKS FAQ

What is the fundamental rating for ALKS stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALKS.


What is the valuation status of ALKERMES PLC (ALKS) stock?

ChartMill assigns a valuation rating of 6 / 10 to ALKERMES PLC (ALKS). This can be considered as Fairly Valued.


Can you provide the profitability details for ALKERMES PLC?

ALKERMES PLC (ALKS) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for ALKS stock?

The Earnings per Share (EPS) of ALKERMES PLC (ALKS) is expected to decline by -20.69% in the next year.